Ireland plays a critical role in supporting AbbVie's international operations. Our new AbbVie North Dublin (AND) facility will be a key node in AbbVie's global Operations network, serving as a European hub bringing together our Dublin-based supply chain, engineering, quality assurance and manufacturing teams for the first time.
AbbVie EVP, Chief Operations Officer
AbbVie
AbbVie was founded in 2013 when it became a separate company from Abbott Laboratories. Headquartered in Chicago, AbbVie are one of the largest biopharmaceutucal companies in the world. Its products treat more than 62 million people every year, affected by over 60 conditions. The company is present in over 70 countries and its total headcount is close to 50,000 people.AbbVie in Ireland
AbbVie’s presence in Ireland dates back to 1974, combining the company’s own investment with facilities acquired through buyouts. It has eight sites in Ireland that, together, employ more than 2,600 people. Its site at Carrigtwohill near Cork celebrated its 20th anniversary in 2022, and the company has plants and office hubs in Dublin, as well as manufacturing medicines for global supply at locations on the west coast of Ireland, at Westport in County Mayo and in Sligo.Ongoing investment
Recent expansion at its site on the outskirts of Cork involves a new €63 million facility using new technologies to support AbbVie’s aesthetics business. The site will employ 70 people in roles including sterile manufacturing, quality control and engineering. The site is due to be operational from 2025.In 2020, when AbbVie completed its buyout of Allergan, the companies opened a second facility in Westport for producing Botox, in a $176 million investment. The 750,000 sq ft site employs 1,400 people.
In 2018, AbbVie spent $139 million on expanding one of its two plants in Sligo, to increase capacity to produce cancer drugs. That followed a $115 million investment four years previously to produce oral hepatitis C drugs in Sligo.
How Ireland Helps AbbVie
- Company presence in Ireland dates back five decades
- Close to 2,600 people employed at AbbVie in Ireland
- Activities in Ireland span commercial and manufacturing
- AbbVie continues to invest in its eight Irish sites spanning the country
Activities in Ireland span commercial and manufacturing
AbbVie continues to invest in its eight Irish sites spanning the country.
AbbVie’s presence in Ireland dates back to 1974.
You Might Also Be Interested In
BioMarin Announces Significant Investment and Expansion of Cork Facility
BioMarin Pharmaceutical Inc. announced a €60 million investment in the expansion of its state-of-the-art facility in Shanbally, Co. Cork., with addition of a new, four-story laboratory facility that will enable the company to increase production capacity for currently approved medicines and create room for future growth.
Read more
Hovione Almost Doubles Spray Drying Capacity With Multi-Million Euro Investment In Cork, Ireland
Hovione, an international pharmaceutical contract development and manufacturing organisation (CDMO), today officially commissioned an expansion at its manufacturing facility in Ringaskiddy, Co. Cork.
Read more
West continues its investment in Ireland with Dublin manufacturing facility expansion
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced an additional 330 roles as part of an expansion of its manufacturing site in Damastown, Dublin. West is supported by the Irish Government, through IDA Ireland.
Read more